← Leaderboards
Jeremy Guttman
Biomotivate, Llc
$613,364
Attributed
$613,364
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $306.9K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$613,364 · 2
By mechanism
R43$613,364 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Relapse Risk”
- Nikej Shah · Nirsum Laboratories, Inc.$12,588,496
- Andrew S Huhn · Johns Hopkins University$12,205,195
- Gary Fanger · Rise Therapeutics, Llc$8,202,376
- Andrew Walker · Emergent Product Development Gaithersbur$6,354,906
- Sunil Kannanganat Sidharthan · Astero Erado Inc$5,289,481
- Zafiris J. Daskalakis · Centre For Addiction And Mental Health$4,706,485
Research focus
Relapse RiskCostPhysiologicalMunicipalitiesPredictive AnalyticsOpioid EpidemicOpioid Use DisorderPharmaceutical PreparationsRelapseResponseFamilyProviderOverdoseCravingMonitorMhealthMotivationMachine Learning AlgorithmIntuitionMachine LearningMedical Care CostsEpidemicBehavioralEarly Treatment
Grant awards (3)
PEACE Platform for Non-Invasive Narrative Neuromodulation (Personalized Evocative Audiovisual Content for Everyone)$306,872
R43 · FY2025 · DA · contact PI
Project Motivate: A digital motivation and prediction platform to improve treatment retention and reduce relapse in opioid use disorder$55,000
R43 · FY2021 · DA · contact PI
Project Motivate: A digital motivation and prediction platform to improve treatment retention and reduce relapse in opioid use disorder$251,492
R43 · FY2020 · DA · contact PI